Also, its abundance is increased in brain diseases like multiple sclerosis [29], Parkinson’s disease [30], and depression [31] The reduction in Akkermansia abundance in the SU-PR group may be explained by the modulation effect on the microbiome induced by the probiotics, helping to maintain a controlled population of mucin-degrading bacteria. This evidence concerns the gene MUC5AC and depressive symptom measurement.